DoD Breast Cancer Research Program

Amount of funding - Level 1: $450,000 direct costs for applications with a single PI or $750,000 direct costs if applying under the Partnering PI Option.
Amount of funding - Level 2: $1M direct costs for applications with a single PI or $1.5M direct costs if applying under the Partnering PI Option.
Purpose:  Funding Level 1 - Innovative, high-risk/high-reward research that is in the earliest stages of idea development or is an untested theory that addresses an important problem. To foster research that yields new avenues of investigation, preliminary data are not required. Proof of concept is the anticipated outcome.
Funding Level 2 - Research that is already supported by substantial preliminary or published data and strongly validates clinical translation in a well-defined context within the breast cancer landscape.
Eligibility: Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI or a Partnering PI.
Instructors and Senior Postdoctoral Fellows are eligible. Instructors and Senior Postdoctoral fellows must submit and obtain approval for a Career Development PI waiver through their RPMs in RMG prior to submitting a pre-application/letter of intent. Instructors and Postdocs cannot be Partnering PIs.
Not eligible: Clinical Instructors, and academic staff-research (i.e, research associates) are not eligible (per confirmation in previous years by Dr. Greenberg & by former Vice Provost and Dean of Research, Dr. Arvin).
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 1, 2023
Application submission Deadline: August 8, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding:  $4M direct costs for applications with a single PI or $5M direct costs if applying under the Partnering PI Option.
Purpose: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are: Impact and Research Scope. 
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI or a Partnering PI.
Not eligible: Instructors, Clinical Instructors, Academic staff-research (i.e., research associates), and postdocs are not eligible for this RFP because Stanford does not consider them to be independent positions.
Timeline:
REQUIRED Pre-Application (Pre-Proposal) Deadline: June 29, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  September 19, 2023
Application Submission Deadline: September 26, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding:  direct costs budgeted for the entire period of performance (single PI or Partnering PI Option) will not exceed $15M.
Purpose:  The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are Impact and Research Scope.
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application) may be the PI or a Partnering PI.
Not eligible: Instructors, Clinical Instructors, Academic staff-research (i.e., research associates), and postdocs are not eligible for this RFP because Stanford does not consider them to be independent positions.
Timeline:
REQUIRED Pre-Application (Pre-Proposal) Deadline: June 29, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  September 19, 2023
Application Submission Deadline: September 26, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding:  Direct costs budgeted for the entire period of performance will not exceed $3M.
Purpose:  The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the “best and brightest” in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.
Eligibility: The guidelines indicate “applicants must be an 'independent investigator' within 6 years of their last training position (e.g., postdoctoral fellowship; medical residency; clinical fellowship)" therefore, only Stanford Assistant Professors with PI eligibility and CE Assistant Professors  (with an approved CE faculty PI waiver obtained through their RPM prior to the pre-application/letter of intent submission) who are within 6 years of their last training position are eligible.
Not eligible: Instructors, Clinical Instructors, Postdoctoral Fellows, Clinical Fellows, Academic staff-researchers (i.e., research associates) are not eligible because Stanford does not consider them to be independent or faculty-level positions)
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 1, 2023
Application submission Deadline: August 8, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding: Direct costs for the entire period of performance will not exceed $7M.
Purpose:  The Innovator Award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer.
Eligibility: PIs must be at or above the level of Associate Professor (with PI eligibility) or CE Associate Professor (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent). 
Timeline:
REQUIRED Pre-Application (Pre-Proposal) Deadline: June 29, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  September 19, 2023
Application Submission Deadline: September 26, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $25M.
Purpose:  The FY23 Transformative Breast Cancer Consortium Award is designed to support collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applicants must bring together different perspectives to develop new paradigms that will solve fundamental yet overarching problems in breast cancer. This award requires a team-based approach by a consortium of exceptional researchers and advocates, whose collaborative efforts will make a transformative impact in breast cancer. The transformation intended by the consortium must be in people’s lives, and not in the healthcare or research system. 
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the Consortium Director or Team PI.
Not eligible: Instructors, Clinical Instructors, Academic staff-research (i.e., research associates), and postdocs are not eligible for this RFP because Stanford does not consider them to be independent positions.
Timeline:
REQUIRED Pre-Application (Pre-Proposal) Deadline: June 29, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  September 19, 2023
Application Submission Deadline: September 26, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $100,000.
Purpose:  The FY23 Transformative Breast Cancer Consortium Development Award is intended to provide successful applicants the time and resources needed to bring investigators and breast cancer advocates together to establish a consortium framework and conduct preliminary research to support application to a future, full Transformative Breast Cancer Consortium Award (pending availability of funds). This is a development award and is a separate mechanism from the full consortium award. Recipients of the FY23 Transformative Breast Cancer Consortium Development Award are expected to submit an application to compete for the full Transformative Breast Cancer Consortium Award anticipated to be offered in a future fiscal year(s). However, it is not necessary to receive a development award in order to apply for a full consortium award in the future. 
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the Consortium Director or Team PI.
Not eligible: Instructors, Clinical Instructors, Academic staff-research (i.e., research associates), and postdocs are not eligible for this RFP because Stanford does not consider them to be independent positions.
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 1, 2023
Application submission Deadline: August 8, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $5M for applications with a single PI or $6M if applying under the Partnering PI Option.
Purpose: The FY23 BCRP Clinical Research Extension Award aims to extend the data collection, followup, and analysis of breast cancer clinical research studies. The intent of this mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to limited or early termination of patient follow-up and sample collection and analysis. 
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the Consortium Director or Team PI.
Not eligible: Instructors, Clinical Instructors, Academic staff-research (i.e., research associates), and postdocs are not eligible for this RFP because Stanford does not consider them to be independent positions.
Timeline:
Pre-Application (Letter of Intent) Deadline: March 28, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  April 4, 2023
Application Submission Deadline: April 11, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/bcrp

Please include your institutional official's name (RPM/RMG or CGO/OSR) as business official in the pre-application/LOI.

eBRAP Funding Opportunities and Forms (including the General Application Instructions).